- Investing Ideas
- /
- Commercial Services Healthcare Sector
Commercial Services Healthcare Sector
Results
2304
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2304 companies
Amarin
Market Cap: US$230.1m
A pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally.
AMRN
US$11.11
7D
5.0%
1Y
-34.5%
Aardvark Therapeutics
Market Cap: US$227.8m
A clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases.
AARD
US$10.50
7D
6.2%
1Y
n/a
Jade Biosciences
Market Cap: US$226.6m
Operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases.
JBIO
US$7.03
7D
-4.3%
1Y
n/a
Optima Health
Market Cap: UK£166.9m
Provides occupational health and wellbeing services for the public and private sectors in the United Kingdom.
OPT
UK£1.88
7D
-2.3%
1Y
n/a
Astria Therapeutics
Market Cap: US$221.2m
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States.
ATXS
US$3.92
7D
-1.0%
1Y
-56.5%
MediWound
Market Cap: US$220.2m
A biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally.
MDWD
US$20.37
7D
-0.5%
1Y
24.3%
Tactile Systems Technology
Market Cap: US$219.0m
A medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States.
TCMD
US$9.42
7D
-9.4%
1Y
-26.7%
Medical Facilities
Market Cap: CA$299.0m
Through its subsidiaries, owns and operates specialty surgical hospitals and ambulatory surgery center in the United States.
DR
CA$15.55
7D
0.06%
1Y
32.7%
Solid Biosciences
Market Cap: US$217.8m
Develops therapies for neuromuscular and cardiac diseases in the United States.
SLDB
US$2.81
7D
1.4%
1Y
-63.9%
Fennec Pharmaceuticals
Market Cap: US$217.4m
Operates as a commercial stage biopharmaceutical company in the United States.
FENC
US$7.87
7D
15.1%
1Y
17.5%
Monopar Therapeutics
Market Cap: US$216.7m
A clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States.
MNPR
US$35.45
7D
-4.6%
1Y
1,027.4%
Design Therapeutics
Market Cap: US$216.3m
A clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States.
DSGN
US$3.81
7D
8.5%
1Y
-12.6%
enGene Holdings
Market Cap: US$216.1m
Through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines to help patients suffering from bladder cancer.
ENGN
US$4.24
7D
22.9%
1Y
-67.0%
OptimizeRx
Market Cap: US$215.5m
Operates as a digital healthcare technology company.
OPRX
US$11.65
7D
1.9%
1Y
-10.0%
Performant Healthcare
Market Cap: US$214.6m
Provides audit, recovery, and analytics services in the United States.
PHLT
US$2.74
7D
2.6%
1Y
-11.3%
Integrated Diagnostics Holdings
Market Cap: US$211.6m
Operates as a consumer healthcare company that provides medical diagnostics services to patients.
IDHC
US$0.36
7D
1.1%
1Y
15.7%
ProKidney
Market Cap: US$208.0m
A clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States.
PROK
US$0.71
7D
-11.9%
1Y
-78.9%
VitaSpring Biomedical
Market Cap: US$207.0m
Focuses on the development of drugs of cell medicine.
VSBC
US$1.00
7D
0%
1Y
n/a
Bright Minds Biosciences
Market Cap: CA$281.8m
A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.
DRUG
CA$39.78
7D
-12.0%
1Y
2,386.3%
Bioventix
Market Cap: UK£151.5m
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.
BVXP
UK£29.00
7D
5.5%
1Y
-32.6%
Actuate Therapeutics
Market Cap: US$202.7m
A clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States.
ACTU
US$10.33
7D
-2.1%
1Y
n/a
Monash IVF Group
Market Cap: AU$311.7m
Provides assisted reproductive and specialist women imaging services in Australia and Malaysia.
MVF
AU$0.80
7D
-5.9%
1Y
-42.9%
Orthocell
Market Cap: AU$310.9m
A regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia, the United States, the United Kingdom, and the European Union.
OCC
AU$1.29
7D
0.8%
1Y
238.2%
Cardiff Oncology
Market Cap: US$201.6m
A clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers.
CRDF
US$3.03
7D
7.8%
1Y
-11.9%
BioStem Technologies
Market Cap: US$200.0m
A life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.
BSEM
US$11.98
7D
-3.3%
1Y
61.8%
Tango Therapeutics
Market Cap: US$199.4m
A precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need.
TNGX
US$1.84
7D
22.7%
1Y
-73.4%
Codexis
Market Cap: US$198.8m
Provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China.
CDXS
US$2.40
7D
-2.8%
1Y
-24.3%
Y-mAbs Therapeutics
Market Cap: US$195.6m
A commercial-stage biopharmaceutical company, focuses on the development and commercialization of radioimmunotherapy and antibody based therapeutic products for the treatment of cancer.
YMAB
US$4.32
7D
5.4%
1Y
-64.6%
4basebio
Market Cap: UK£144.1m
Engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally.
4BB
UK£11.25
7D
0%
1Y
-19.9%
UroGen Pharma
Market Cap: US$193.2m
Engages in the development and commercialization of solutions for urothelial and specialty cancers.
URGN
US$4.19
7D
-42.7%
1Y
-68.4%
ME Therapeutics Holdings
Market Cap: CA$261.9m
A preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology.
METX
CA$10.00
7D
-2.9%
1Y
150.6%
SOPHiA GENETICS
Market Cap: US$190.4m
Operates as a cloud-native software technology company in the healthcare space.
SOPH
US$2.85
7D
-3.7%
1Y
-39.7%
CARGO Therapeutics
Market Cap: US$189.1m
A clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients.
CRGX
US$4.10
7D
-0.5%
1Y
-80.3%
OraSure Technologies
Market Cap: US$188.5m
Develops, manufactures, markets, sells, and distributes diagnostic products, specimen collection devices, and other diagnostic products in the United States, Europe, Africa, and internationally.
OSUR
US$2.52
7D
3.7%
1Y
-48.0%
Quanterix
Market Cap: US$188.3m
A life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions.
QTRX
US$4.85
7D
1.3%
1Y
-70.5%
Pacific Smiles Group
Market Cap: AU$287.7m
Owns and operates dental centers under the Pacific Smiles Dental Centres and Nib Dental Care Centres names in Australia.
PSQ
AU$1.78
7D
0%
1Y
-6.3%